by
Astrid Fiano, DOTmed News Writer | September 16, 2009
--An excise tax of 35 percent on insurance companies and plan administrators for any plan above the threshold of $8,000 for singles and $21,000 for family plans.
--An annual flat fee of $2.3 billion for pharmaceutical manufacturers allocated according to market share except for those companies with sales of $5 million or less.

Ad Statistics
Times Displayed: 138115
Times Visited: 7975 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
--An annual flat fee of $4 billion for medical device manufacturers allocated according to market share and also not applicable to companies with sales of $5 million or less.
--An annual flat fee of $6 billion for health insurance companies allocated according to market share.
--An annual flat fee of $750 million on clinical laboratories allocated according to market share.
The complete Chairman's Mark may be accessed at: http://finance.senate.gov/sitepages/leg/LEG%202009/091609%20Americas_Healthy_Future_Act.pdf
Senator's Baucus' comments may be accessed at: http://finance.senate.gov/press/Bpress/2009press/prb091609.pdf
Read AdvaMed's statement by clicking on DOTmed's Press Room.
Back to HCB News